AJOVista LLC purchased a new stake in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 1,056 shares of the specialty pharmaceutical company’s stock, valued at approximately $58,000. Other hedge funds and other institutional investors […]
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Free Report) CEO Nikhil Lalwani sold 16,292 shares of the stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $67.13, for a total value of $1,093,681.96. Following the transaction, the chief executive officer now directly owns 411,629 shares in […]
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Free Report) CEO Nikhil Lalwani sold 16,292 shares of ANI Pharmaceuticals stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $67.13, for a total value of $1,093,681.96. Following the completion of the transaction, the chief executive officer now owns 411,629 shares […]
ANI Pharmaceuticals (NASDAQ:ANIP – Get Free Report) is scheduled to be releasing its earnings data before the market opens on Thursday, February 29th. Analysts expect ANI Pharmaceuticals to post earnings of $0.80 per share for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link. ANI […]